Le-Le Zhang

Dr. Le-Le Zhang

School of Basic Medical Sciences, Chengdu University, Chengdu, Sichuan, China
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in The American Journal of Chinese Medicine
Verified
Journal Article
Closed access
LZLe-Le Zhang
Le-Le Zhang
KTKe Tian
Ke Tian
ZTZheng-Hai Tang
Zheng-Hai Tang
XCXiao-Jia Chen
Xiao-Jia Chen
ZBZhao-Xiang Bian
Zhao-Xiang Bian
Jin-Jian LuJin-Jian Lu
Jin-Jian Lu

18 February 2014 in Advanced Functional Materials
Verified
Journal Article
Closed access
PDF file
RLRuizheng Liang
Ruizheng Liang
RTRui Tian
Rui Tian
LMLina Ma
Lina Ma
LZLe-Le Zhang
Le-Le Zhang
YHYanli Hu
Yanli Hu
XDXue Duan
Xue Duan

4 July 2018 in Chinese Medicine
Verified
Journal Article
Open access
PDF file
MHMu-Yang Huang
Mu-Yang Huang
LZLe-Le Zhang
Le-Le Zhang
JDJian Ding
Jian Ding
Jin-Jian LuJin-Jian Lu
Jin-Jian Lu
Cancer is still presenting a serious threat to human health worldwide. The understanding of the complex biology of cancer and the development of oncotherapy have led to increasing treatment approaches such as targeted therapy and immunotherapy. Chinese medicinal herbs have attracted considerable attention due to their potential anticancer effects. Some natural products or formulae from Chinese medicinal herbs with directly or indirectly anticancer effects have been reported. In this article, we summarized the current progression on development of anticancer drugs from Chinese medicinal herbs, toward providing ideas for further development and application of Chinese medicinal herbs in cancer therapy.

29 June 2017 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
LZLe-Le Zhang
Le-Le Zhang
WXWen Xu
Wen Xu
YXYu‐Lian Xu
Yu‐Lian Xu
XCXiuping Chen
Xiuping Chen
MHMing-Qing Huang
Ming-Qing Huang
Jin-Jian LuJin-Jian Lu
Jin-Jian Lu

7 September 2017 in Acta Pharmacologica Sinica
Verified
Journal Article
Closed access
XJXiao-Ming Jiang
Xiao-Ming Jiang
YXYu-Lian Xu
Yu-Lian Xu
MHMu-Yang Huang
Mu-Yang Huang
LZLe-Le Zhang
Le-Le Zhang
MSMin-Xia Su
Min-Xia Su
Jin-Jian LuJin-Jian Lu
Jin-Jian Lu

27 December 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
FSFeiya SHENG
Feiya SHENG
LZLe-Le Zhang
Le-Le Zhang
SWSongsong Wang
Songsong Wang
LYLele Yang
Lele Yang
PLPeng Li
Peng Li
Microglia mediated neuronal inflammation has been widely reported to be responsible for neurodegenerative disease. Deacetyl ganoderic acid F (DeGA F) is a triterpenoid isolated from Ganoderma lucidum, which is a famous edible and medicinal mushroom used for treatment of dizziness and insomnia in traditional medicine for a long time. In this study the inhibitory effects and mechanisms of DeGA F against lipopolysaccharide (LPS)-induced inflammation both in vitro and in vivo were investigated. On murine microglial cell line BV-2 cells, DeGA F treatment inhibited LPS-triggered NO production and iNOS expression and affected the secretion and mRNA levels of relative inflammatory cytokines. DeGA F inhibited LPS-induced activation of the NF-κB pathway, as evidenced by decreased phosphorylation of IKK and IκB and the nuclear translocation of P65. In vivo, DeGA F treatment effectively inhibited NO production in zebrafish embryos. Moreover, DeGA F suppressed the serum levels of pro-inflammatory cytokines, including TNF-α and IL-6 in LPS-stimulated mice model. DeGA F reduced inflammatory response by suppressing microglia and astrocytes activation and also suppressed LPS-induced NF-κB activation in mice brains. Taken together, DeGA F exhibited remarkable anti-inflammatory effects and promising therapeutic potential for neural inflammation associated diseases.